结果页面 13，板块：医疗保健，行业：生物技术，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- Amsterdam (3)
- ASX (49)
- Brussels (6)
- BSE (9)
- Canadian Sec (21)
- Cboe CA (3)
- Copenhagen (5)
- Frankfurt (395)
- Helsinki (4)
- HKSE (46)
- IOB (24)
- Istanbul (1)
- KOSDAQ (10)
- KSE (10)
- MCE (4)
- MCX (2)
- Mexico (22)
- Milan (3)
- Munich (17)
- NSE (10)
- NYSE (6)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (41)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (30)
- OTC Markets OTCQX (6)
- Paris (27)
- São Paulo (14)
- Shanghai (46)
- Shenzhen (45)
- Stockholm (55)
- Stuttgart (24)
- Swiss (8)
- Taipei Exchange (53)
- Taiwan (7)
- Tech Market Large (156)
- Tech Market Middle (85)
- Tech Market Small (211)
- Tel Aviv (12)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (16)
- Vienna (11)
- Warsaw (8)
- XETRA (13)
医疗保健 (1697)
- {{item.name}}
- 所有版块
- 医疗保健 (1697)
生物技术 (1697)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | 预测 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | 预测 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Green Cross Holdings Corporation 005250.KS | ₩16,960 12.8 USD |
+1.98
|
₩777B 586.15M USD | ₩151K 114.03 USD | ₩16,570 12.51 USD | ₩17,060 12.88 USD | ₩777B 586.15M USD | 0 | ₩0 0 USD | ||
| Prestige BioPharma Limited 950210.KS | ₩12,920 9.75 USD |
+0.08
|
₩776B 586.09M USD | ₩96K 72.25 USD | ₩12,670 9.56 USD | ₩13,020 9.83 USD | ₩776B 586.09M USD | 0 | ₩0 0 USD | ||
| Opthea OPT | $3.41 — |
0
|
$583.10M — | $0.00 — | $0.00 — | $0.00 — | $583.10M — | 0 | $0.00 — | ||
| Opthea Limited UKJ2.F | €3.00 3.28 USD |
0
|
€512.99M 560.77M USD | €0.00 0 USD | €3.00 3.28 USD | €3.00 3.28 USD | €512.99M 560.77M USD | 0 | -€1.94 -2.1 USD | ||
| Takara Bio Inc. TF2.F | €3.94 4.31 USD |
+1.55
|
€512.76M 560.51M USD | €814.00 889.81 USD | €3.94 4.31 USD | €4.10 4.48 USD | €512.76M 560.51M USD | 0 | -€0.29 -0.3 USD | ||
| Opthea Limited OPT.AX | A$0.60 0.4 USD |
0
|
A$820.79M 543.24M USD | A$6.21M 4.11M USD | A$0.60 0.39 USD | A$0.62 0.41 USD | A$820.79M 543.24M USD | 0 | -A$0.43 -0.2 USD | ||
| NovaBridge Biosciences IMAB | $4.63 — |
0
|
$533.68M — | $0.00 — | $0.00 — | $0.00 — | $533.68M — | 0 | $0.00 — | ||
| Viva Biotech Holdings VBIZF | $0.25 — |
0
|
$521.29M — | $100.00 — | $0.29 — | $0.29 — | $521.29M — | 24.71 | $0.01 — | ||
| Altimmune, Inc. 3G0.F | €4.56 4.99 USD |
+0.68
|
€475.91M 520.23M USD | €100.00 109.31 USD | €4.56 4.99 USD | €4.56 4.99 USD | €475.91M 520.23M USD | 0 | -€0.91 -0.9 USD | ||
| Prothena Corporation plc 0PT.F | €8.65 9.46 USD |
+0.58
|
€475.36M 519.63M USD | €3.00 3.28 USD | €8.65 9.46 USD | €8.65 9.46 USD | €475.36M 519.63M USD | 0 | -€4.44 -4.8 USD | ||
| Cellectis S.A. ZVA.F | €4.62 5.05 USD |
+13.51
|
€463.50M 506.67M USD | €57.00 62.31 USD | €4.62 5.05 USD | €4.62 5.05 USD | €463.50M 506.67M USD | 0 | -€0.28 -0.3 USD | ||
| Cellectis S.A. ZVAA.F | €4.48 4.9 USD |
+5.16
|
€449.46M 491.32M USD | €6.05K 6.61K USD | €4.48 4.9 USD | €4.48 4.9 USD | €449.46M 491.32M USD | 0 | -€0.28 -0.3 USD | ||
| Viva Biotech Holdings VB0.F | €0.21 0.23 USD |
+1.98
|
€447.29M 488.95M USD | €1.26K 1.38K USD | €0.21 0.23 USD | €0.21 0.23 USD | €447.29M 488.95M USD | 20.60 | €0.01 0.01 USD | ||
| Nxera Pharma Co., Ltd. JSS.F | €4.84 5.29 USD |
+5.68
|
€446.63M 488.23M USD | €2.00 2.19 USD | €4.62 5.05 USD | €4.84 5.29 USD | €446.63M 488.23M USD | 0 | -€0.20 -0.2 USD | ||
| Avacta AVCTF | $1.11 — |
0
|
$481.37M — | $29.57K — | $1.11 — | $1.11 — | $481.37M — | 0 | -$0.15 — | ||
| Opthea Limited UKJ.F | €0.32 0.35 USD |
0
|
€437.75M 478.52M USD | €7.00K 7.65K USD | €0.32 0.35 USD | €0.32 0.35 USD | €437.75M 478.52M USD | 0 | -€0.25 -0.2 USD | ||
| Bicycle Therapeutics plc 50BA.F | €5.95 6.5 USD |
-1.65
|
€436.21M 476.84M USD | €20.00 21.86 USD | €5.95 6.5 USD | €6.10 6.67 USD | €436.21M 476.84M USD | 0 | -€3.09 -3.3 USD | ||
| Niagen Bioscience, Inc. OCD1.F | €5.40 5.9 USD |
+0.93
|
€432.20M 472.46M USD | €1.00K 1.09K USD | €5.40 5.9 USD | €5.40 5.9 USD | €432.20M 472.46M USD | 27.00 | €0.20 0.22 USD | ||
| Newron Pharmaceuticals S.p.A. NP5.F | €21.60 23.61 USD |
+5.11
|
€431.16M 471.31M USD | €4.08K 4.45K USD | €20.90 22.85 USD | €22.30 24.38 USD | €431.16M 471.31M USD | 15.88 | €1.36 1.49 USD | ||
| Nxera Pharma SOLTF | $5.11 — |
-1.54
|
$462.43M — | $1.20K — | $5.54 — | $5.60 — | $462.43M — | 0 | -$0.23 — | ||
| Autolus Therapeutics plc 6A3A.F | €1.38 1.51 USD |
+5.34
|
€414.54M 453.14M USD | €500.00 546.57 USD | €1.34 1.46 USD | €1.38 1.51 USD | €414.54M 453.14M USD | 0 | -€0.71 -0.7 USD | ||
| Formycon AG FYB.F | €23.40 25.58 USD |
-1.06
|
€413.35M 451.84M USD | €602.00 658.07 USD | €23.40 25.58 USD | €23.95 26.18 USD | €413.35M 451.84M USD | 0 | -€9.67 -10.5 USD | ||
| Cellectis S.A. CMVLF | $4.50 — |
0
|
$451.46M — | $2.00K — | $4.50 — | $4.50 — | $451.46M — | 0 | -$0.33 — | ||
| Ocugen, Inc. OCGN.MX | MX$23.00 1.36 USD |
-2.54
|
MX$7.50B 443.9M USD | MX$20.00 1.18 USD | MX$23.00 1.36 USD | MX$23.00 1.36 USD | MX$7.50B 443.9M USD | 0 | -MX$4.00 -0.2 USD | ||
| Zevra Therapeutics, Inc. 1GDA.F | €7.05 7.71 USD |
-0.7
|
€402.92M 440.45M USD | €500.00 546.57 USD | €7.05 7.71 USD | €7.05 7.71 USD | €402.92M 440.45M USD | 17.62 | €0.40 0.44 USD | ||
| Avacta Group Plc RTQ1.F | €0.86 0.94 USD |
+1.18
|
€397.34M 434.35M USD | €6.00K 6.56K USD | €0.86 0.94 USD | €0.86 0.94 USD | €397.34M 434.35M USD | 0 | -€0.13 -0.1 USD | ||
| Clinuvel Pharmaceuticals CLVLF | $8.12 — |
+1.75
|
$431.49M — | $600.00 — | $7.50 — | $7.50 — | $431.49M — | 16.91 | $0.48 — | ||
| Clinuvel Pharmaceuticals Limited CLVLY | $8.31 — |
-1.19
|
$418.68M — | $140.00 — | $8.20 — | $8.42 — | $418.68M — | 17.31 | $0.48 — | ||
| Dishman Carbogen Amcis Limited DCAL.NS | ₹219.68 2.66 USD |
-0.06
|
₹34.55B 417.98M USD | ₹203.09K 2.46K USD | ₹217.40 2.63 USD | ₹225.01 2.72 USD | ₹34.55B 417.98M USD | 25.25 | ₹8.70 0.11 USD | ||
| Dishman Carbogen Amcis Limited DCAL.BO | ₹220.05 2.66 USD |
+0.27
|
₹34.50B 417.39M USD | ₹9.67K 116.93 USD | ₹217.30 2.63 USD | ₹225.00 2.72 USD | ₹34.50B 417.39M USD | 25.26 | ₹8.71 0.11 USD | ||
| NovaBridge Biosciences 0VY.F | €3.28 3.59 USD |
-1.8
|
€378.07M 413.28M USD | €846.00 924.79 USD | €3.28 3.59 USD | €3.28 3.59 USD | €378.07M 413.28M USD | 0 | -€0.43 -0.4 USD | ||
| PureTech Health PRTC | $17.04 — |
0
|
$411.83M — | $363.00 — | $17.04 — | $17.04 — | $411.83M — | 10.02 | $1.70 — | ||
| PureTech Health PTCHF | $1.68 — |
0
|
$406.03M — | $1.00K — | $1.70 — | $1.70 — | $406.03M — | 9.88 | $0.17 — | ||
| Akebia Therapeutics, Inc. AX9.F | €1.38 1.51 USD |
+2.29
|
€367.27M 401.47M USD | €100.00 109.31 USD | €1.38 1.51 USD | €1.38 1.51 USD | €367.27M 401.47M USD | 0 | -€0.07 -0.07 USD | ||
| Immutep PRRUF | $0.27 — |
+3.85
|
$397.42M — | $5.00K — | $0.25 — | $0.26 — | $397.42M — | 0 | -$0.04 — | ||
| Clinuvel Pharmaceuticals Limited UR9.F | €7.00 7.65 USD |
-0.85
|
€361.80M 395.5M USD | €175.00 191.3 USD | €7.00 7.65 USD | €7.00 7.65 USD | €361.80M 395.5M USD | 17.07 | €0.41 0.45 USD | ||
| Enanta Pharmaceuticals, Inc. 9EP.F | €12.30 13.45 USD |
+4.24
|
€360.08M 393.62M USD | €54.00 59.03 USD | €11.70 12.79 USD | €12.40 13.55 USD | €360.08M 393.62M USD | 0 | -€3.28 -3.5 USD | ||
| Galectin Therapeutics Inc. PHPN.F | €5.20 5.68 USD |
+10.64
|
€352.75M 385.61M USD | €78.00 85.26 USD | €4.82 5.27 USD | €5.20 5.68 USD | €352.75M 385.61M USD | 0 | -€0.50 -0.5 USD | ||
| Clinuvel Pharmaceuticals Limited UR9A.F | €6.70 7.32 USD |
-4.29
|
€346.30M 378.55M USD | €1.68K 1.84K USD | €6.70 7.32 USD | €6.70 7.32 USD | €346.30M 378.55M USD | 16.34 | €0.41 0.45 USD | ||
| Hansa Biopharma AB (publ) 24H.F | €3.26 3.56 USD |
-0.12
|
€343.14M 375.09M USD | €2.93K 3.2K USD | €3.26 3.56 USD | €3.26 3.56 USD | €343.14M 375.09M USD | 0 | -€0.84 -0.9 USD | ||
| Vanda Pharmaceuticals Inc. VM4.F | €5.50 6.01 USD |
-5.17
|
€337.10M 368.5M USD | €700.00 765.19 USD | €5.50 6.01 USD | €5.50 6.01 USD | €337.10M 368.5M USD | 0 | -€1.23 -1.3 USD | ||
| Flerie AB (publ) 1NP.F | €4.16 4.55 USD |
+1.96
|
€325.60M 355.93M USD | €1.00 1.09 USD | €4.03 4.41 USD | €4.14 4.53 USD | €325.60M 355.93M USD | 0 | -€8.83 -9.6 USD | ||
| Rocket Pharmaceuticals, Inc. 9IP1.F | €2.75 3 USD |
-5.02
|
€324.71M 354.95M USD | €3.00 3.28 USD | €2.75 3 USD | €2.75 3 USD | €324.71M 354.95M USD | 0 | -€1.92 -2.09 USD | ||
| Immutep Limited YP1A.F | €2.20 2.4 USD |
+5.77
|
€323.82M 353.98M USD | €1.20K 1.31K USD | €2.20 2.4 USD | €2.20 2.4 USD | €323.82M 353.98M USD | 0 | -€0.31 -0.3 USD | ||
| PureTech Health plc 0VQ0.F | €12.90 14.1 USD |
-0.77
|
€311.77M 340.81M USD | €0.00 0 USD | €12.90 14.1 USD | €12.90 14.1 USD | €311.77M 340.81M USD | 8.89 | €1.45 1.59 USD | ||
| Gongwin Biopharm Holdings Co., Ltd. 6617.TWO | NT$87.40 2.78 USD |
-0.68
|
NT$10.72B 340.54M USD | NT$232.66K 7.39K USD | NT$85.00 2.7 USD | NT$88.50 2.81 USD | NT$10.72B 340.54M USD | 0 | -NT$0.71 -0.02 USD | ||
| Immutep Limited YP1B.F | €0.18 0.2 USD |
-4.69
|
€302.48M 330.65M USD | €4.00K 4.37K USD | €0.18 0.2 USD | €0.18 0.2 USD | €302.48M 330.65M USD | 0 | -€0.03 -0.03 USD | ||
| Avalo Therapeutics Inc. R C6K0.F | €16.46 17.99 USD |
-2.02
|
€298.49M 326.28M USD | €64.00 69.96 USD | €16.46 17.99 USD | €16.46 17.99 USD | €298.49M 326.28M USD | 0 | -€11.47 -12.5 USD | ||
| Mereo BioPharma Group plc MAH0.F | €1.87 2.04 USD |
-4.35
|
€297.58M 325.29M USD | €1.00K 1.09K USD | €1.87 2.04 USD | €1.87 2.04 USD | €297.58M 325.29M USD | 0 | -€0.21 -0.2 USD | ||
| AC Immune SA IMR.F | €2.95 3.22 USD |
+9.89
|
€296.27M 323.86M USD | €3.97K 4.34K USD | €2.95 3.22 USD | €3.15 3.44 USD | €296.27M 323.86M USD | 0 | -€0.77 -0.8 USD | ||
| Mereo BioPharma Group plc MAH0.SG | €1.86 2.03 USD |
-3.39
|
€295.19M 322.68M USD | €0.00 0 USD | €1.86 2.03 USD | €1.86 2.03 USD | €295.19M 322.68M USD | 0 | -€0.21 -0.2 USD | ||
| Larimar Therapeutics, Inc. ZA71.F | €3.36 3.67 USD |
+1.82
|
€291.57M 318.73M USD | €158.00 172.72 USD | €3.36 3.67 USD | €3.36 3.67 USD | €291.57M 318.73M USD | 0 | -€1.68 -1.8 USD | ||
| Antengene Corporation Limited 722.F | €0.46 0.5 USD |
+3.6
|
€291.05M 318.15M USD | €103.00 112.59 USD | €0.46 0.5 USD | €0.46 0.5 USD | €291.05M 318.15M USD | 0 | -€0.04 -0.04 USD | ||
| Anavex Life Sciences Corp. 12X1.F | €3.17 3.47 USD |
-7.44
|
€283.59M 310M USD | €100.00 109.31 USD | €3.17 3.47 USD | €3.39 3.7 USD | €283.59M 310M USD | 0 | -€0.46 -0.5 USD | ||
| Frontage FGHQF | $0.15 — |
0
|
$303.75M — | $130.00 — | $0.15 — | $0.15 — | $303.75M — | 0 | $0.00 — | ||
| Saniona AB (publ) 30S.F | €1.97 2.16 USD |
+3.03
|
€273.44M 298.91M USD | €830.00 907.3 USD | €1.97 2.16 USD | €1.97 2.16 USD | €273.44M 298.91M USD | 4.38 | €0.45 0.49 USD | ||
| Protara Therapeutics, Inc. 1KPA.F | €5.00 5.47 USD |
+5.49
|
€273.42M 298.89M USD | €388.00 424.14 USD | €5.00 5.47 USD | €5.00 5.47 USD | €273.42M 298.89M USD | 0 | -€1.19 -1.3 USD | ||
| XOMA Royalty Corporation X0M1.F | €22.00 24.05 USD |
-23.08
|
€272.43M 297.8M USD | €310.00 338.87 USD | €22.00 24.05 USD | €22.20 24.27 USD | €272.43M 297.8M USD | 34.37 | €0.64 0.7 USD | ||
| Astria Therapeutics, Inc. 2090.MU | €4.74 5.18 USD |
0
|
€267.40M 292.3M USD | €108.00 118.06 USD | €4.74 5.18 USD | €4.74 5.18 USD | €267.40M 292.3M USD | 0 | -€44.71 -48.8 USD | ||
| Hansa Biopharma AB (publ) HNSBF | $2.91 — |
0
|
$290.20M — | $150.00 — | $2.93 — | $2.93 — | $290.20M — | 0 | -$0.98 — | ||
| Genfit S.A. XUPB.F | €4.96 5.42 USD |
+5.08
|
€263.21M 287.72M USD | €840.00 918.23 USD | €4.96 5.42 USD | €4.96 5.42 USD | €263.21M 287.72M USD | 0 | -€0.78 -0.8 USD | ||
| Genfit S.A. XUP.SG | €5.18 5.66 USD |
+5.54
|
€262.65M 287.11M USD | €0.00 0 USD | €5.18 5.66 USD | €5.18 5.66 USD | €262.65M 287.11M USD | 0 | -€0.78 -0.8 USD | ||
| scPharmaceuticals Inc. 2SX.F | €4.76 5.2 USD |
0
|
€261.18M 285.51M USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €261.18M 285.51M USD | 0 | €0.00 0 USD | ||
| Genfit S.A. XUP.F | €5.11 5.58 USD |
+5.39
|
€260.82M 285.12M USD | €100.00 109.31 USD | €5.11 5.58 USD | €5.11 5.58 USD | €260.82M 285.12M USD | 0 | -€0.78 -0.8 USD | ||
| SELLAS Life Sciences Group, Inc. RXK3.F | €1.72 1.88 USD |
+5.41
|
€254.30M 277.99M USD | €17.29K 18.9K USD | €1.72 1.88 USD | €1.79 1.96 USD | €254.30M 277.99M USD | 0 | -€0.24 -0.2 USD | ||
| Oryzon Genomics ORYZF | $3.36 — |
0
|
$273.46M — | $5.00K — | $3.03 — | $3.03 — | $273.46M — | 0 | -$0.04 — | ||
| Oryzon Genomics S.A. ORN.F | €3.11 3.39 USD |
+0.16
|
€249.12M 272.32M USD | €50.00 54.66 USD | €3.11 3.39 USD | €3.11 3.39 USD | €249.12M 272.32M USD | 0 | -€0.03 -0.03 USD | ||
| Silence Therapeutics plc XRP2.F | €5.25 5.74 USD |
-2.78
|
€247.98M 271.07M USD | €1.50K 1.64K USD | €5.25 5.74 USD | €5.25 5.74 USD | €247.98M 271.07M USD | 0 | -€1.15 -1.2 USD | ||
| Vicore Pharma Holding AB (publ) 6Y4.F | €0.88 0.96 USD |
-2.66
|
€247.46M 270.51M USD | €1.00K 1.09K USD | €0.88 0.96 USD | €0.88 0.96 USD | €247.46M 270.51M USD | 0 | -€0.18 -0.1 USD | ||
| Panacea Biotec Limited PANACEABIO.NS | ₹363.25 4.39 USD |
+9.31
|
₹22.25B 269.18M USD | ₹273.57K 3.31K USD | ₹333.00 4.03 USD | ₹369.95 4.48 USD | ₹22.25B 269.18M USD | 0 | -₹1.20 -0.01 USD | ||
| Panacea Biotec Limited PANACEABIO.BO | ₹362.70 4.39 USD |
+9.53
|
₹22.22B 268.77M USD | ₹9.07K 109.71 USD | ₹335.00 4.05 USD | ₹370.00 4.48 USD | ₹22.22B 268.77M USD | 0 | -₹1.19 -0.01 USD | ||
| Fennec Pharmaceuticals Inc. FRX.TO | CA$10.60 7.87 USD |
0
|
CA$362.03M 268.65M USD | CA$19.00 14.1 USD | CA$10.60 7.87 USD | CA$10.60 7.87 USD | CA$362.03M 268.65M USD | 0 | -CA$0.36 -0.2 USD | ||
| Genfit S.A. XUPB.MU | €4.90 5.36 USD |
+3.81
|
€245.12M 267.95M USD | €0.00 0 USD | €4.90 5.36 USD | €4.90 5.36 USD | €245.12M 267.95M USD | 0 | -€0.78 -0.8 USD | ||
| Silence Therapeutics SLNCF | $1.80 — |
0
|
$255.06M — | $600.00 — | $1.80 — | $1.80 — | $255.06M — | 0 | -$0.45 — | ||
| Aldeyra Therapeutics, Inc. 137.F | €3.83 4.19 USD |
-1.49
|
€230.60M 252.08M USD | €1.50K 1.64K USD | €3.83 4.19 USD | €4.11 4.49 USD | €230.60M 252.08M USD | 0 | -€0.62 -0.6 USD | ||
| Genfit S.A. GNFT | $4.85 — |
0
|
$244.43M — | $0.00 — | $0.00 — | $0.00 — | $244.43M — | 0 | $0.00 — | ||
| Onward Medical N.V. 63E.F | €3.95 4.32 USD |
+0.38
|
€223.09M 243.87M USD | €140.00 153.04 USD | €3.92 4.29 USD | €4.00 4.37 USD | €223.09M 243.87M USD | 0 | -€0.74 -0.8 USD | ||
| Enlivex Therapeutics Ltd. 1BT.F | €0.81 0.88 USD |
0
|
€220.41M 240.94M USD | €5.00K 5.47K USD | €0.81 0.88 USD | €0.81 0.88 USD | €220.41M 240.94M USD | 0 | -€0.46 -0.5 USD | ||
| Fennec Pharmaceuticals Inc. RV41.F | €6.25 6.83 USD |
-1.57
|
€218.42M 238.76M USD | €0.00 0 USD | €6.10 6.67 USD | €6.25 6.83 USD | €218.42M 238.76M USD | 0 | -€0.22 -0.2 USD | ||
| Oncoinvent ASA BRRGF | $0.97 — |
0
|
$237.33M — | $37.31K — | $0.02 — | $0.02 — | $237.33M — | 0 | -$2.04 — | ||
| MediWound Ltd. M8W.F | €16.70 18.26 USD |
-1.76
|
€214.12M 234.06M USD | €215.00 235.02 USD | €16.20 17.71 USD | €16.70 18.26 USD | €214.12M 234.06M USD | 0 | -€1.57 -1.7 USD | ||
| Voyager Therapeutics, Inc. VYGR.MX | MX$71.00 4.2 USD |
0
|
MX$3.95B 233.75M USD | MX$0.00 0 USD | MX$71.00 4.2 USD | MX$71.00 4.2 USD | MX$3.95B 233.75M USD | 0 | -MX$39.40 -2.3 USD | ||
| Hansa Biopharma AB (publ) 0RC7.IL | SEK 36.12 3.53 USD |
-0.71
|
SEK 2.38B 231.97M USD | SEK 20.98K 2.05K USD | SEK 35.84 3.5 USD | SEK 36.22 3.54 USD | SEK 2.38B 231.97M USD | 0 | -SEK 16.03 -1.5 USD | ||
| Genor Biopharma Holdings Limited 67N0.F | €0.38 0.41 USD |
-3.57
|
€211.44M 231.14M USD | €3.06K 3.34K USD | €0.38 0.41 USD | €0.38 0.41 USD | €211.44M 231.14M USD | 37.79 | €0.01 0.01 USD | ||
| Heron Therapeutics, Inc. AXD2.F | €1.15 1.25 USD |
0
|
€209.95M 229.5M USD | €100.00 109.31 USD | €1.15 1.25 USD | €1.15 1.25 USD | €209.95M 229.5M USD | 0 | -€0.08 -0.08 USD | ||
| Editas Medicine, Inc. 8EM.F | €2.14 2.34 USD |
-0.7
|
€209.20M 228.68M USD | €2.00 2.19 USD | €2.13 2.32 USD | €2.14 2.34 USD | €209.20M 228.68M USD | 0 | -€2.01 -2.1 USD | ||
| Achieve Life Sciences, Inc. SP4P.F | €3.93 4.29 USD |
+1.55
|
€208.94M 228.4M USD | €2.58K 2.82K USD | €3.93 4.29 USD | €3.93 4.29 USD | €208.94M 228.4M USD | 0 | -€1.15 -1.2 USD | ||
| ProQR Therapeutics N.V. 0PQ.F | €1.97 2.16 USD |
+7.52
|
€207.85M 227.2M USD | €2.62K 2.87K USD | €1.97 2.16 USD | €1.97 2.16 USD | €207.85M 227.2M USD | 0 | -€0.41 -0.4 USD | ||
| Voyager Therapeutics, Inc. VT6.F | €3.58 3.91 USD |
+0.45
|
€204.73M 223.8M USD | €150.00 163.97 USD | €3.58 3.91 USD | €3.58 3.91 USD | €204.73M 223.8M USD | 0 | -€1.85 -2.02 USD | ||
| Atrys Health, S.A. A2T.F | €2.59 2.83 USD |
+0.78
|
€203.02M 221.93M USD | €588.00 642.76 USD | €2.37 2.59 USD | €2.61 2.85 USD | €203.02M 221.93M USD | 0 | -€0.32 -0.3 USD | ||
| BioInvent International AB (publ) BOVNF | $3.29 — |
0
|
$216.40M — | $908.00 — | $4.70 — | $4.70 — | $216.40M — | 0 | -$0.47 — | ||
| Genfit S.A. GNFTF | $4.14 — |
0
|
$215.44M — | $100.00 — | $4.14 — | $4.14 — | $215.44M — | 0 | -$0.91 — | ||
| Egetis Therapeutics AB (publ) P0F.F | €0.44 0.49 USD |
+7.51
|
€192.37M 210.29M USD | €100.00 109.31 USD | €0.44 0.49 USD | €0.44 0.49 USD | €192.37M 210.29M USD | 0 | -€0.08 -0.08 USD | ||
| VitaSpring Biomedical VSBC | $1.00 — |
0
|
$207.03M — | $63.00 — | $0.50 — | $0.50 — | $207.03M — | 0 | $0.00 — | ||
| Egetis Therapeutics AB (publ) P0F.SG | €0.45 0.49 USD |
+6.24
|
€187.63M 205.11M USD | €0.00 0 USD | €0.45 0.49 USD | €0.45 0.49 USD | €187.63M 205.11M USD | 0 | -€0.08 -0.08 USD | ||
| Armata Pharmaceuticals, Inc. TG1N.F | €4.82 5.27 USD |
+2.12
|
€184.50M 201.69M USD | €1.00K 1.09K USD | €4.82 5.27 USD | €4.82 5.27 USD | €184.50M 201.69M USD | 0 | -€1.42 -1.5 USD | ||
| BioInvent International AB (publ) 0H22.IL | SEK 28.53 2.78 USD |
+1.69
|
SEK 2.01B 195.91M USD | SEK 418.00 40.8 USD | SEK 28.50 2.78 USD | SEK 28.50 2.78 USD | SEK 2.01B 195.91M USD | 0 | -SEK 5.01 -0.4 USD | ||
| Tiziana Life Sciences Ltd 0RP.F | €1.48 1.62 USD |
-0.67
|
€176.52M 192.96M USD | €1.98K 2.16K USD | €1.42 1.55 USD | €1.48 1.62 USD | €176.52M 192.96M USD | 0 | -€0.10 -0.1 USD | ||
| Healios K.K. 6VX.F | €1.47 1.61 USD |
-9.26
|
€176.04M 192.43M USD | €350.00 382.6 USD | €1.47 1.61 USD | €1.47 1.61 USD | €176.04M 192.43M USD | 0 | -€0.33 -0.3 USD | ||
| BioInvent International AB (publ) BIX0.F | €2.55 2.78 USD |
+0.79
|
€171.57M 187.55M USD | €20.00 21.86 USD | €2.55 2.78 USD | €2.55 2.78 USD | €171.57M 187.55M USD | 0 | -€0.45 -0.4 USD | ||
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
|||||||||||